By TKG’s Co-Founder John Strapp
At The Kinetix Group we’re not just concerned with great methodology, but also seeking out technology that can ease the transition between payment models, drive behavioral change and analyze data while providing actionable reports to providers. That’s why we’ve partnered with COTA Inc., which has created a groundbreaking cloud-based data platform called COTA, which stands for “Cancer Outcomes Tracking and Analysis.”
Built by and for oncologists, COTA’s ability to analyze precise real world data has the capacity to be a game-changer. The technology is designed to collect clinical and financial data in order to better recommend specific treatment options for cancer subtypes. What we find intriguing about COTA compared to similar platforms is that over the past 10 years, teams of oncologists and leaders in cancer biostatics and reimbursement contributed data to the platform, generating a digital map of all cancer, called COTA Nodal Addresses (CNA). CNAs can then take into account diagnostic and prognostic information as well as therapy and progression statuses, providing oncologists with comparative data to make efficient decisions on the most effective approaches.
With its precise classifications and a synchronized use of data, COTA continuously improves insights while creating national outcomes benchmarks and empowering patients. And because of the rich real-time clinical outcomes and cost-analysis data that COTA can sift through, this powerful tool can be applied to oncology-specific bundled payments – something we have highlighted to fellow partners working on the triple aim and that’s been endorsed by numerous payors as the data analytic for cancer care.
So far, The Kinetix Group has introduced the technology to national medical organizations and brought COTA on board with a hospital group for an upcoming pilot program. That three-month pilot will conclude with a detailed post-pilot report – a look at the optimized outcomes possible with powerful technology integration at their clinical practices. We look forward to sharing that data later in the first quarter.